Critical Limb Ischemia Market Outlook 2025-2035: The 7 major critical limb ischemia market reached a value of USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 2.5 ...

Diabetes mellitus type 1 (DM1) is associated with lower probability of incident cardiovascular events than type 2 (DM ...

In a secondary analysis of the BEST-CLI trial, McGinigle et al found lower rates of major adverse limb events (MALE) and ...

Acute limb ischemia (ALI) results from a sudden obstruction in the arterial flow to the extremity due to an embolism or thrombosis. Embolic problems result in a greater degree of ischemia than ...

Critical limb-threatening ischemia represents the end stage of peripheral artery disease. About 2 million Americans have ...

Acute limb ischemia occurs due to a sudden decrease in the blood flow to a limb, resulting in a potential threat to the viability of the extremity. Unfortunately, the threat is not only to the ...

1 In its most severe form, critical limb ischemia patients are often treated with lower extremity amputation (LEA). 2 “We are dedicated to expanding innovative treatment options for peripheral ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 ...

Objective To determine which primary endovascular revascularisation strategy represents the most clinically effective treatment for patients with chronic limb threatening ischaemia who require ...

AMBITION BTK is a multicenter, randomized controlled trial (RCT) designed to evaluate the clinical outcomes of the Auryon Atherectomy System in combination with standard balloon angioplasty compared ...

A report published on 12 February 2025 in the Journal of the Society for Cardiovascular Angiography and Interventions by Dr ...